DUBLIN--(BUSINESS WIRE)--GE Healthcare today presented the results of a randomised controlled study analyzing the effect of DaTSCAN™ (Ioflupane I 123 Injection) SPECT imaging in a group of adult ...
Ronald M. Schwartz, MD, of the Neurological Research Center at Hattiesburg Clinic, MS gives an interview about the DaTscan test, an imaging agent that was approved by the FDA this year. The DaTscan is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results